Clinical Trial Update: Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating adalimumab optimization in rheumatoid arthritis using therapeutic drug monitoring (TDM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Reade Rheumatology Research Institute | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING